Industry Analysis & Industry Trends
The Biotechnology industry investigates and capitalises on the commercial applications of biological manipulation. It is fast becoming a prominent part of the UK life sciences scene alongside pharmaceutical and medical technology firms. The convergence of these three technologies is making it increasingly difficult to identify the boundaries between them. The Biotechnology industry relies heavily on third-party financing, so the economic downturn posed significant funding challenges. Low business confidence made private financiers uncertain about investing in risky research and development (R&D) projects. This dampened growth, but could not contain it... purchase to read more
Industry Report - Industry Analysis Chapter
Bioscience has been declared a national priority by the British government. The industry relies heavily on government financing because it struggles to attract private investment for pioneering speculative research. The long investment horizon means that even established biotechnology ventures face challenges when raising capital for product development. The relative youth of the industry does not help matters. After existing for about 30 years, the Biotechnology industry has only recently become profitable and is slowly moving to reduce its reliance on governmental support.
Overall, growth in the industry tends to be determined by the rate at which products can be developed and brought to market... purchase to read more